Jump to content

User:MDElliottMD/Sandbox/CYP1A2: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

19 May 2026

  • curprev 22:3922:39, 19 May 2026 MDElliottMD talk contribs 66 bytes −17,538 Redirect to canonical enzyme sandbox location. This User: page was a cross-session sandbox-location duplication artifact; the canonical enzyme sandbox pages live under Pharmacopedia:Pharmacogenomics sandbox/Enzyme <NAME>. Content (full retrofitted version) is preserved at the canonical title. Tag: New redirect
  • curprev 22:0322:03, 19 May 2026 MDElliottMD talk contribs 17,604 bytes +17,604 Sandbox-save CYP1A2 enzyme entity page (8th pharmacogenomics enzyme page). History-first spine: Anthony Conney enzyme-induction research (Hoffmann-La Roche, Nutley NJ), 1982 Clowes Memorial Lecture PMID 6814745, AhR induction mechanism. 28-row collapsible-sortable substrate table (clozapine/olanzapine/theophylline/tizanidine headline substrates; caffeine probe; antidepressants, triptans, others). Phenotype section: honest no-PM/IM/NM-bedside-classification (like CYP3A4); variability dominated...
Retrieved from "https://pharmacopedia.wiki/p/User:MDElliottMD/Sandbox/CYP1A2"